| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | Feb 27, 2024 | ARVINAS, INC. | Chief Medical Officer | Sell | 95.0 | +37,551 | 125.32% | ✗ | $79.9K |
| Aug 11, 2023 | Aug 14, 2023 | ARVINAS, INC. | Chief Medical Officer | Sell | 46.3 | -1,324 | -4.23% | ✗ | $32.3K |
| Aug 12, 2022 | Aug 16, 2022 | ARVINAS, INC. | Chief Medical Officer | Sell | 42.5 | -1,258 | -13.37% | ✗ | $69K |
| Aug 12, 2022 | Aug 16, 2022 | ARVINAS, INC. | Chief Medical Officer | Sell | 42.5 | -1,258 | -13.37% | ✗ | $86.8K |
| Dec 30, 2021 | Jan 4, 2022 | ARVINAS, INC. | Chief Medical Officer | Sell | 5.0 | -20,000 | -78.73% | ✓ | $1.6M |
| Aug 12, 2021 | Aug 16, 2021 | ARVINAS, INC. | Chief Medical Officer | Sell | 42.5 | -1,363 | -20.15% | ✗ | $123.4K |
| Jun 30, 2021 | Jul 2, 2021 | ARVINAS, INC. | Chief Medical Officer | Sell | 5.0 | -20,000 | -87.90% | ✓ | $1.5M |
| Feb 16, 2021 | Feb 18, 2021 | ARVINAS, INC. | Chief Medical Officer | Sell | 5.0 | -20,000 | -87.90% | ✓ | $1.5M |
| Aug 14, 2020 | Aug 18, 2020 | ARVINAS, INC. | Chief Medical Officer | Sell | 46.3 | -1,256 | -31.32% | ✗ | $34.5K |